Medical and Pharmaceutical
Natera (NASDAQ:NTRA) acquired full enrolment for the RenaCARE (Renasight Clinical Application, Review and Evaluation) study, which is a prospective, multi-center clinical trial to determine...
Hi, what are you looking for?
Mugglehead Investment Magazine
News
Business
The store is the third Budega dispensary in Los Angeles and is set to open later this year
Business
Darren Karasiuk was the previous CEO of Nova Cannabis
Business
Curaleaf to acquire complete control of Four 20 Pharma within two years of the commencement of adult use in Germany.
Business
The Rio de Janeiro clinic has a capacity of 23,000 patient consultations per year
Cyber Security
Atrion pulled in USD$14 million in revenue with a profit of USD$3.3 million and EBITDA of USD$533,300.
Alternative Energy
Here are five companies pulling wealth out of the ground.
Business
The last store in Niagara, Ontario is still pending regulatory approvals
Business
The isolate will go to MINO Labs, a specialty pharma and medical supply distributor
Crypto/Blockchain
